Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 1997

View Archived Issues

New alpha1-adrenoceptor antagonists from Roche

New antiasthma agents reported by Sandoz

Antifungal echinocandin derivatives reported by Lilly

Novel cytotoxic protein derived from bacterial source

ACCORD study results reported in Circulation

Roche presents new antifungal agents

MMP inhibitors disclosed by Fuji Yakuhin

Cerebrus discovers role of gene in obesity

Glaxo Wellcome selects anticonvulsant compound for further study

Thrombin inhibitors submitted to SAR studies at DuPont Merck

Merck & Co. investigates thrombin inhibitors

Additional beneficial lipid-modifying effects of FCP-3P1 reported

Merck Frosst discovers orally active COX-2 inhibitors

ICOS MAb to enter clinic

Positive phase II results reported for platelet substitute

SIBIA receives patent coverage for antiparkinson compounds

Brain cancer gene identified

Boston Life Sciences demonstrates efficacy of antiangiogenic factor

GEM-132 enters clinic in U.S.

Oncor technology covered by U.S. patent

New H. pylori test enters clinic

GelTex reports CholestaGel phase II data

Company Profile: Molecular Design International

Fujisawa investigates tachykinin antagonists

Muse licensed to Janssen for certain markets

Abbott seeks expanded labeling for Norvir

Phase I trials begin for Fabry's disease

ERT and the renin-angiotensin system in postmenopausal women

Royce Laboratories receives FDA approval for alprazolam

FDA approves Royce's generic narcotic pain reliever

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...